Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Transl Res. 2014 Mar 13;165(1):18–27. doi: 10.1016/j.trsl.2014.03.004

Epigenetic regulation of open chromatin in pluripotent stem cells

Hiroshi Kobayashi 1, Nobuaki Kikyo 1
PMCID: PMC4163141  NIHMSID: NIHMS577258  PMID: 24695097

Abstract

The recent progress in pluripotent stem cell research has opened new avenues of disease modeling, drug screening, and transplantation of patient-specific tissues that had been unimaginable until a decade ago. The central mechanism underlying pluripotency is epigenetic gene regulation; the majority of cell signaling pathways, both extracellular and cytoplasmic, eventually alter the epigenetic status of their target genes during the process of activating or suppressing the genes to acquire or maintain pluripotency. It has long been thought that the chromatin of pluripotent stem cells is globally open to enable the timely activation of essentially all genes in the genome during differentiation into multiple lineages. The current article reviews descriptive observations and the epigenetic machinery relevant to what is supposed to be globally open chromatin in pluripotent stem cells. This includes microscopic appearance, permissive gene transcription, chromatin remodeling complexes, histone modifications, DNA methylation, noncoding RNAs, dynamic movement of chromatin proteins, nucleosome accessibility and positioning, and long-range chromosomal interactions. Detailed analyses of each element, however, have revealed that the globally open chromatin hypothesis is not necessarily supported by some of the critical experimental evidence, such as genome-wide nucleosome accessibility and nucleosome positioning. Further understanding of the epigenetic gene regulation is expected to determine the true nature of the so-called globally open chromatin in pluripotent stem.

Introduction

It is generally accepted that chromatin in pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced PSCs (iPSCs), is globally decondensed or “open” so that the cells can readily express many genes as they become necessary for differentiation into many lineages. Although the idea of open chromatin in PSCs is not novel, the recent progress in PSC biology, in particular the creation of iPSCs,1 uncovered new pieces of evidence that potentially explain mechanistic links between pluripotency and open chromatin. A major impetus for this progress has been various types of genome-wide surveys, represented by the international effort of the ENCODE (Encyclopedia of DNA Elements) project.2–6 As of December 2013, this project had uncovered a wide spectrum of epigenetic modifications, including histone modifications, DNA methylation, transcription factor binding, chromatin accessibility, and long-range chromosomal interactions, in 338 human cell types and 86 mouse cell types, including ESCs. In addition, the U.S. National Institutes of Health (NIH) Roadmap Epigenomics Consortium has published genome-wide analyses of histone modifications, DNA methylation, and chromatin accessibility with an emphasis on stem cells, including ESCs and iPSCs, and their differentiated derivatives.7,8 Supported by the invention of sophisticated tools for chromatin analyses and bioinformatics, the explosive advance of this field is expected to continue at an accelerated pace. Because epigenetic regulation in PSCs has been discussed in many review articles,9–17 the current article will focus on epigenetic regulation that is directly relevant to globally open chromatin in PSCs. Methodological aspects of genome-wide epigenetic studies have also been reviewed elsewhere18 and will not be covered here.

Chromatin decondensation at the microscopic level

The initial evidence for the presence of open chromatin in undifferentiated cells came from morphological studies at the microscopic level. Long before mouse ESCs were created in 198119 and pluripotency became a major cell biological research field, gradual, unidirectional, and global chromatin condensation was well documented with Wright stain during differentiation of hematopoietic cells.20,21 Densely stained areas (heterochromatin) within the nucleus gradually increase and become coarse and granular during differentiation of cells of each hematopoietic lineage. This observation is even more conspicuous with transmission electron microscopy, which shows an increase of electron-dense material that is initially scattered in local patches and eventually occupies wide areas, sometimes more than half of the nuclear space.20–22 Electron microscopy also displays fine, evenly distributed granules in the ESC nucleus that become more irregularly clustered after differentiation.23 Although the electron-dense materials represent poorly characterized aggregations of DNA, protein, and RNA, and their precise functions remain unknown, they are generally interpreted to represent condensed chromatin and provide evidence that condensed chromatin increases during differentiation of undifferentiated cells, including PSCs.

In addition to the nucleus-wide chromatin condensation, centromeres have served as a model structure that undergoes condensation during differentiation of PSCs. Round centromeric heterochromatin looks more diffuse in ESCs than in neural progenitor cells differentiated from the same ESCs when stained with an antibody against the heterochromatin protein HP1a, which is highly enriched in centromeres.24 The total level of HP1a also increases during differentiation. Fluorescence in situ hybridization (FISH) of the major satellite DNA sequence, one of the dominant DNA sequences of centromeres, also demonstrates more diffuse distribution in ESCs than in neural progenitor cells.24

Permissive transcription

Another observation frequently cited as evidence for open chromatin in PSCs came from transcriptome studies comparing ESCs and differentiated cells.23, 25 ESCs contain twice as much total RNA and mRNA, normalized to the amount of DNA, as neural progenitor cells.23 Microarray studies indicated that whereas differentiated cells generally express 10–20% of all mRNA species, ESCs express 30–60% of all mRNA species.25 The mRNAs expressed in ESCs include those of many tissue-specific genes that do not appear to be necessary for maintaining the undifferentiated state of ESCs. Although some of the tissue-specific genes are expressed at very low levels,23 others are translated into proteins,26 indicating that they are not artifacts of detection by sensitive PCR. This permissive transcriptional environment is not limited to PSCs; hematopoietic stem cells also express non-hematopoietic genes, which are gradually downregulated during differentiation.27,28

Although these findings may fit the interpretation of uncontrolled leaky transcription due to open chromatin, definitive evidence is still missing. It is also possible that the primary cause of the prevalent transcription is as-yet-uncharacterized functions of the transcription machinery rather than the chromatin structure as a substrate for transcription. Chromatin immunoprecipitation and DNA microarray (ChIP-chip) and genome-wide nuclear run-on experiments indicated that RNA polymerase II is paused at the promoters of 40–50% of all the protein-coding genes without elongation of mRNA in ESCs, suggesting that post-initiation processes are the rate-limiting steps in transcription.25,26 Although this high frequency of paused polymerase may look to be a promising explanation for the permissive expression in ESCs, similar results have in fact been obtained with differentiated cells, such as hepatocytes, B cells, and embryonic fibroblasts.29,30 Thus, the link between permissive transcription and polymerase II pausing has not been established.29, 30

Chromatin remodeling complexes

Chromatin remodeling complexes potentially play key roles in the permissive transcription in ESCs. The complexes use ATP to relax DNA-histone interactions and thereby increase the fluidity of chromatin structure.31,32 They comprise 4 families (SWI/SNF [switching defective/sucrose nonfermenting], also called BAF [Brg/Brahma-associated factor]; ISWI [imitation switch]; CHD [chromodomain, helicase, and DNA binding]; and INO80 [inositol requiring 80]) and are involved in almost all types of chromatin activities, including transcription, DNA repair, and DNA replication.31,32 Not surprisingly, many subunits of the complexes are essential for the maintenance of pluripotency and proliferation of ESCs, as recently reviewed.10 In addition, many of the subunits are highly expressed in ESCs. Efroni et al. reported that out of 25 detectable subunits, 20 are significantly downregulated during differentiation of ESCs to neural progenitor cells and 5 are slightly upregulated.23

Chd1, the catalytic subunit of the CHD complex, is necessary for the maintenance of open chromatin in ESCs.33 Genome-wide binding sites of Chd1 correlate well with those of trimethylation of lysine 4 of histone H3 (H3K4me3; a marker for active genes) and RNA polymerase II, suggesting a role for Chd1 in gene activation. Knockdown of Chd1 in ESCs converts diffuse centromeric heterochromatin into more compact structures, as observed with the immunofluorescence staining of H3K9me3 (a marker for suppressed genes), which is enriched at centromeric heterochromatin, and its binding protein HP1γ. However, Chd1 knockdown decreases the expression of only 26 genes in addition to Chd1 itself, potentially due to functional redundancy with other chromatin remodeling complexes. Although ESCs with Chd1 knockdown can maintain an undifferentiated state, the cells lose the ability to differentiate into primitive endoderm, and they tend instead to differentiate into neural lineages, indicating that Chd1 is necessary for the maintenance of pluripotency.

esBAF is an ESC-specific SWI/SNF complex that is also required for the maintenance of pluripotency in ESCs.34,35 esBAF colocalizes with the 3 master transcription factors of pluripotency—Oct4, Sox2, and Nanog—in the ESC genome and is essential for sustaining the core pluripotency transcriptional network.34 Although Brg1, the catalytic (ATPase) subunit of esBAF, is widely expressed in differentiated cells as well, esBAF is characterized by the presence or absence of specific subunits. For example, the BAF170 subunit is absent from esBAF, whereas it is present in other SWI/SNF complexes; ESCs overexpressing BAF170 proliferate less competitively than non-transduced cells when these 2 cell types are co-cultured. The BAF155 subunit is present in esBAF and its depletion leads to decreased cell proliferation, downregulated Oct4 expression, and increased apoptosis.36 This subunit is required for heterochromatin formation during differentiation of ESCs but its role in open chromatin remains unknown.36

Histone modifications

Histones of ESCs are characterized by an increased amount of modifications that are involved in gene activation (H3K4me3, acetylation of lysine 9 on histone H3 [H3K9ac], H3K14ac, and H4ac) and a decreased amount of the modification that is a hallmark for gene suppression (H3K9me3) compared with those in differentiated cells.23,24,37 In addition, large chromosomal regions of up to 4.9 Mb enriched with H3K9me2 called LOCKs (large organized chromatin K9 modifications) are markedly decreased in ESCs compared with differentiated cells38: LOCKs cover 4% of the genome in ESCs, in contrast to 31% in differentiating ESCs and 46% in liver cells. Importantly, genes located within LOCKs are generally suppressed, providing another example of ESC-specific open chromatin. These specific increases and decreases of histone modifications are potentially relevant to the permissive transcription in ESCs.

Polycomb Repressive Complex 1 and 2 (PRC1 and PRC2) are two of the most extensively studied histone modifying complexes that are involved in gene suppression in general.39–42 PRC2 contains Suz12, Ezh2, Eed, and RbAp46/48 as core components and induces H3K27me2 and H3K27me3 through the methyltransferase activity of Ezh2. H3K27me2 and H3K27me3 recruit PRC1, which induces monoubiquitylation of H2AK119 with the ubiquitin ligases Ring1A and Ring1B in PRC1; however, the link between PRC2 and PRC1 remains controversial.42 H3K27me3 is a well-established marker for suppressed genes, typically existing at the promoters and transcriptional initiation sites of these genes. Although several mechanisms have been proposed, the exact mechanism of suppression remains elusive.

PRC2 binds to 200–500 genes in the ESC genome, many of which encode transcription factors important for differentiation.43,44 These suppressed genes are marked with H3K27me3 in ESCs and become activated during differentiation of ESCs concomitant with the loss of PRC2. Knockout of the PRC2 components indicated that PRC2 is not essential for ESCs to maintain an undifferentiated state despite global depletion of H3K27me3; however, PRC2 is required for proper differentiation of the cells.45–47

Many promoters in ESCs are marked by the co-existence of H3K4me3 (active genes) and H3K27me3 (suppressed genes), which is called a bivalent mark. H3K27me3 is lost when the gene is activated, and H4K4me3 is lost when the gene remains suppressed during differentiation. Based on these findings, these marks were initially thought to indicate pluripotency-specific genes in ESCs that are poised to be activated when they become necessary during differentiation.48,49 However, subsequent studies showed that a bivalent mark is not unique to ESCs,50–52 and H3K27me3 is not necessary to maintain the undifferentiated state of ESCs.45 The functions and molecular mechanisms underlying bivalent marks were thoroughly discussed in a recent review article.49

DNA methylation

The promoters of suppressed genes are frequently marked by methylation of cytosine (5-methylcytosine or 5mC) at the CpG sequence.53,54 Although, as mentioned earlier, ESCs express more mRNA species than differentiated cells, the global level of 5mC at CpG sites is similar in ESCs and differentiated cells.55,56 However, 5mC at non-CpG sites is uniquely abundant in ESCs56, 57: whereas both human fibroblasts and ESCs contain 45 million 5mCs at CpG sites, ESCs harbor 17 million 5mCs at non-CpG sites and fibroblasts harbor almost none.56 The non-CpG 5mC is enriched in gene bodies and disappears upon differentiation of ESCs; however, the functions of non-CpG 5mC, including their connection to open chromatin, are largely unknown.

New 5mCs are established by the de novo DNA methyltransferases Dnmt3a and Dnmt3b. Once established, 5mC is maintained during DNA replication by Dnmt1. ESCs prepared from Dnmt1 knockout mice and single and double Dnmt3a and Dnmt3b knockout mice can remain undifferentiated despite a significant loss of 5mC, although proper differentiation of ESCs with Dnmt1 knockout and Dnmt3a/b double knockout is disrupted.58–60

All three Ten-eleven Translocation proteins (Tet1, Tet2, and Tet3) sequentially oxidize 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC).61–63 Thymine DNA glycosylation and base excision repair can convert 5fC and 5caC to cytosine, resulting in demethylation of the original 5mC.61–63 Whereas Tet1 and Tet2 are highly expressed in ESCs and downregulated during differentiation, Tet3 is upregulated during differentiation.64,65 The level of 5hmC, which is primarily maintained by Tet1 and Tet2 in ESCs, also decreases during differentiation of the cells.64–66 5hmC is enriched within exons, enhancers, and promoters of active and inactive genes; thus, unlike 5mC, 5hmC is not tightly correlated with the status of gene activity.67 Single knockout of Tet1 or Tet2, and double-knockout of Tet1 and Tet2 do not compromise the undifferentiated state of ESCs, although differentiation of the Tet1 knockout and the double knockout ESCs is skewed toward endoderm and trophectoderm.64,66,68 The double-knockout completely depletes 5hmC; however, gene expression is altered 1.5-fold or more only in 500 genes.66 Overall, 5mC and 5hmC, as well as their responsible enzymes, are not needed for ESCs to proliferate and remain undifferentiated. However, ESCs cannot differentiate into the full spectrum of lineages without these enzymes, which indicates the essential roles for these DNA modifications for maintaining the pluripotency of ESCs. Whether or not ESCs can retain open chromatin without these modifications requires further study. However, the limited differentiation potential suggests that open chromatin is lost locally at relevant genes in the absence of these DNA modifications.

Noncoding RNAs

microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are also involved in the regulation of chromatin structure in PSCs. miRNAs are generally 20–21 bases in length and bind to target mRNAs, most commonly at the 3' untranslated region (UTR), which leads to degradation or translational inhibition of the target mRNAs.69 miRNAs indirectly control chromatin structure through modulating the protein level of various chromatin-modifying proteins. For example, the miR-290 cluster, which contains miR-290 through miR-295, maintains the levels of Dnmt3a and Dnmt3b potentially by repressing inhibitors of Dnmt3, such as Rbl2, in ESCs.70 In contrast, miR-29b represses Dnmt3a and Dnmt3b and contributes to the formation of iPSCs.71 The miR-125 and miR-181 families provide another example of the miRNAs-chromatin connection in PSCs. These miRNAs are induced during differentiation of ESCs and downregulate their target Cbx7, a pro-self-renewal component of PRC1. Loss of Cbx7 de-represses pro-differentiation components of PRC1, such as Cbx2 and Cbx4.72,73

lncRNAs are defined as RNAs longer than 200 bases that are not mRNA, rRNA, or tRNA.74,75 PSCs express unique lncRNAs that bind to specific chromatin modifying enzymes and recruit these proteins to the binding sites of the lncRNAs in the genome. Guttman et al. found that 74 ESC-enriched lncRNAs are bound to many chromatin modifying proteins, including PRC2, Jarid1c H3K4 demethylase, and Eset H3K9 methyltransferase.76 Two other ESC-enriched lncRNAs called lncRNA_ES1 and lncRNA_ES2 also associate with the PRC2 component Suz12, promoting the maintenance of pluripotency of ESCs.77 These examples demonstrate indirect roles of lncRNAs in the regulation of chromatin structure primarily through the targeting of chromatin modifying proteins to specific genomic loci. Because the function of lncRNAs is so diverse, future study may discover lncRNAs that directly alter chromatin structure through the interaction with DNA or histone.

Dynamic movement of chromatin proteins

Chromatin proteins within the nucleoplasm move more rapidly in ESCs than in differentiated cells, as was shown with the fluorescence recovery after photobleaching (FRAP) technique.24 In a typical FRAP experiment, a cDNA encoding a chromatin protein is fused with a fluorescent protein gene, most commonly green fluorescent protein (GFP), and transfected into tissue culture cells. A small area within a nucleus that expresses the GFP-fusion gene is exposed to high-intensity laser light to irreversibly bleach the GFP signal in the area. The time course of the loss and recovery of the GFP signal in the area is then followed. The recovery of the GFP signal indicates the migration of GFP-fused protein from the surrounding areas, which reflects the size of the freely movable pool of the protein, the release of the proteins from their binding sites in the surrounding areas, and the speed of the migration, among other factors.78 When GFP was fused to HP1α, the linker histone variant H1°, and core histones, Meshorer et al. found that the GFP signal for all these proteins recovers more rapidly in ESCs than in neural progenitor cells.24 Salt extraction of these proteins from chromatin also indicates weaker binding of the proteins to chromatin in ESCs than in neural progenitor cells. These results are interpreted to indicate that ESCs harbor more dynamic chromatin than differentiated cells. The recovery of the GFP signal of GFP-histone H1 is facilitated in ESCs by 1 of 3 manipulations: increased histone acetylation, decreased H3K9 methylation, and decreased lamin A, providing mechanistic connections between protein movement and epigenetics.79 The mobility of histone H1 is not affected by reductions in DNA methylation induced by chemicals or by reductions in nucleosome repeat length, which is the average distance between two adjacent nucleosomes, by depletion of linker histone H1 variants.

In addition to the movement of individual chromatin proteins, chromatin vibrates as a mass at a frequency of 10 to 100 Hz in ESCs (called breathing).80 This was detected as a back-and-forth shift of the areas densely stained with the DNA dye Hoechst 33342 within a distance of 90 to 100 nm. The chromatin breathing becomes weak as early as 3 days after initiation of ESC differentiation and is completely lost by 15 days after initiation of differentiation. Furthermore, the breathing is dependent on ATP, which might be used as a substrate for chromatin remodeling complexes, although this possibility has not been experimentally tested.

Nucleosome accessibility and positioning

Increased accessibility of chromatin to DNase I or restriction enzymes is commonly used as a measure of open chromatin. The pattern of genome-wide distribution of DNase I hypersensitivity sites (DHSs) has been compared between ESCs and many differentiated cell types.81,82 DHSs are generally depleted of nucleosomes and are typically observed at gene regulatory regions, including promoters, enhancers, and insulators. The total number of DHSs is similar in ESCs and 6 differentiated cell lines.82 This result is consistent with a finding independently obtained with chromatin fragmentation by sonication in a FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) experiment.82 When an open chromatin site is defined as a site that is hypersensitive to both DNase I and sonication, cell type-specific open chromatin sites are usually located at the regulatory regions of key transcription factor genes that define the identity of the cell type. For instance, there are many open chromatin sites around Oct4 and Nanog that are specific to ESCs.82 However, the number of open chromatin sites defined by these techniques is not necessarily higher in ESCs than in differentiated cells, which contradicts the notion of globally open chromatin in ESCs.

In a related approach, nucleosome positioning has been compared between different cell types. Positioning of nucleosomes in the genome is determined by many factors, including DNA sequence and the presence of chromatin remodeling complexes and transcription factors.83 A genome-wide study of nucleosome positioning detected a difference in nucleosome repeat length: 186 base pairs in ESCs and 191–193 base pairs in differentiated cells.84 Whether this seemingly subtle difference has a functional consequence in gene expression awaits further investigation.

Long-range chromosomal interactions

Many types of cells display specific patterns of intra- and interchromosomal interactions as another layer of epigenetic gene regulation. These chromosomal interactions are studied with the techniques called chromosome conformation capture (3C) and its genome-wide variants.85 Although these techniques differ in the comprehensiveness of the coverage of interactions, in principle they involve crosslinking of interacting chromatin, fragmentation of DNA with restriction enzymes, ligation of nearby DNA fragments, and identification of ligated DNA sequences with PCR or next-generation sequencing technology. Results obtained with these techniques can be independently verified with FISH, which can detect interacting DNA sequences as the colocalization of two fluorescent signals.

Kagey et al. were the first to demonstrate a physical interaction between an enhancer and a promoter via the formation of a chromosomal loop within the Oct4 and Nanog pluripotency gene loci in mouse ESCs.86 The interaction is mediated by the binding of cohesin, which promotes sister chromatid cohesion, and the coactivator complex called mediator to the enhancers and promoters. Later, a cohesin-dependent enhancer–promoter interaction was also reported at the OCT4 locus in human ESCs.87 Extending these studies of local chromosomal interactions, a genome-wide study unraveled numerous chromosomal interactions in PSCs, some of which are specific to pluripotency as shown by the loss of the interactions after differentiation of the cells.88–93 These interactions are generally dependent on the presence of mediator, cohesin, and the CCCTC-binding factor (CTCF), which serves as an insulator dividing 2 chromosomal domains.94 In addition, the pluripotency transcription factors Oct4, Sox2, and Klf4 mediate the chromosomal network between pluripotency genes and non-pluripotency genes. These findings suggest that PSCs harbor a sophisticated network of chromosomal interactions to organize co-regulated gene expression; however, it remains to be studied how many of the observed chromosomal interactions have functional roles.

Chromosomes are also associated with lamin B1, a major meshwork component of the nuclear lamina underlying the nuclear envelope, at more than 1000 loci in ESCs.95 The genes located within the chromosome domains attached to the nuclear envelope via lamin B1 tend to be transcriptionally inactive; the genes encoded in chromosomal loops that protrude into the nuclear interior from the nuclear envelope tend to be transcriptionally active. This conformation dramatically changes during differentiation of ESCs depending on the activity of each gene. Overall, these studies underscore the potential significance of large-scale chromosome–chromosome and chromosome–lamin B1 interactions in the regulation of pluripotency. A critical question relevant to the current article is how to reconcile the open and dynamic chromatin structure in ESCs with the intricate chromosome meshwork that potentially limits chromatin dynamism. Chromosomal interaction is one of the most rapidly progressing areas in the research of stem cell epigenetics, and we expect that this question will be addressed at some point.

Future perspectives

In summary, the notion of globally open chromatin in PSCs is supported by some, but not all, evidence, and we await definitive data. The supportive evidence includes morphological observations, permissive transcription, dynamic movement of chromatin proteins, and chromatin breathing as phenomenological findings (Table 1). Specific epigenetic markers, such as the total amount of various histone markers and the presence of specific chromatin remodeling complexes, also support the idea of open chromatin. Although 5mC, 5hmC, and H3K27me3 are not necessary for ESCs to remain undifferentiated, they potentially contribute to the maintenance of open chromatin in undifferentiated ESCs because ESCs display skewed differentiation patterns without these modifications; however, this interpretation requires verification. In contrast, indicators of physically relaxed chromatin, such as nucleosome accessibility, nucleosome repeat length, and chromosomal interactions, have not provided decisive evidence supporting the open chromatin interpretation. In fact, the studies of nucleosome accessibility, which is one of the parameters most relevant to open chromatin, using 2 independent approaches indicated that there is no significant difference between ESCs and differentiated cells. The lack of physical evidence for the globally open chromatin suggests that the difference of chromatin structure between PSCs and differentiated cells is more subtle than anticipated. Overall, further study is required to uncover the exact structure of what is supposed to be globally open chromatin in PSCs that can be explained by specific molecules unique to ESCs.

Table 1.

Summary of epigenetic markers relevant to globally open chromatin in pluripotent stem cells.

Epigenetic marker Pluripotent stem cell (PSC)-specific feature Relevance to globally open chromatin
Morphological appearance Diffuse centromeric heterochromatin Suggestive
Fine and homogeneous electron-dense materials Suggestive but identity of the electron-dense material remains unknown
Permissive gene transcription More mRNA species Suggestive but other interpretations possible
Chromatin remodeling complexes 20 complexes more abundant Can relax DNA-histone interactions
Chd1 Relaxes centromeric heterochromatin
Necessary for dynamic movement of HP1γ
esBAF Unknown
Histone modifications H3K4me3, H3K9ac, H3K14ac, and H4ac: PSCs > differentiated cells Suggestive
LOCKs (H3K9me2): PSCs < differentiated cells Sussestive
H3K27me3 Required for pluripotency but link to open chromatin is unknown
DNA methylation Number of 5mC at CpG: PSCs = differentiated cells Required for pluripotency but link to open chromatin is unknown
Number of 5mC at non-CpG: PSCs > differentiated cells Unknown
Number of 5hmC: PSCs > differentiated cells Required for pluripotency but link to open chromatin is unknown
miRNAs and lncRNAs Some are specifically expressed in ESCs Involved in pluripotency but link to open chromatin is unknown
Dynamic movement of chromatin proteins FRAP: PSCs > differentiated cells Sign of chromatin flexibility?
Chromatin breathing Unique to PSCs Sign of chromatin flexibility?
Nucleosome accessibility PSCs = differentiated cells Contradictory to open chromatin
Nucleosome repeat length PSCs < differentiated cells Unknown functional meaning
Long-range chromosomal interactions Cell type–specific interactions exist Unknown
Chromosome-lamin B1 interaction Cell type–specific interactions exist Unknown

Another important issue in the context of epigenetics and pluripotency is the true nature of pluripotency itself. Oct4, Nanog, and Sox2 have long been thought to maintain pluripotency through suppression of differentiation-specific genes because they bind to regulatory regions of many lineage-specific transcription factor genes.96,97 However, a cluster of recent studies indicated that pluripotency is in fact acquired and maintained through the tug of war of differentiation toward opposing fates (Oct4 to mesendoderm, Nanog to endoderm, and Sox2 to ectoderm) and the resulting mutual inhibition of differentiation into any specific germ layer cell types.98,99 For example, Oct4 promotes mesendoderm differentiation and suppresses ectodermal differentiation of ESCs, whereas Sox2 induces ectodermal differentiation and inhibits mesendodermal differentiation.100,101 Indeed, iPSCs can be created by transduction of lineage-specific transcription factor genes instead of pluripotency factor genes.102, 103 Therefore, pluripotent chromatin does not necessarily indicate chromatin purposefully kept half-open for future differentiation. Rather, it could be more appropriate to envision a composite of different sets of half-activated genes, each driven by a master differentiation transcription factor.

Acknowledgement

We are grateful to the U.S. National Institutes of Health (R01 GM098294) and the Engdahl Family Foundation for their support of our work related to this topic.

Abbreviations

DHS

DNase I hypersensitivity site

ESC

embryonic stem cell

FISH

fluorescence in situ hybridization

GFP

green fluorescent protein

iPSC

induced pluripotent stem cell

5mC

5-methylcytosine

PRC1 and 2

Polycomb Repressive Complex 1 and 2

PSC

pluripotent stem cell

Tet

Ten-eleven translocation

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

All authors have read the journal's authorship agreement and the manuscript has been reviewed by and approved by all named authors. All authors have read the journal's policy on disclosure of potential conflicts of interest. There is no conflict of interest.

References

  • 1.Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76. doi: 10.1016/j.cell.2006.07.024. [DOI] [PubMed] [Google Scholar]
  • 2.Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–89. doi: 10.1101/gr.132159.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Banfai B, Jia H, Khatun J, et al. Long noncoding RNAs are rarely translated in two human cell lines. Genome Res. 2012;22:1646–57. doi: 10.1101/gr.134767.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Consortium TEP An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74. doi: 10.1038/nature11247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Karolchik D, Barber GP, Casper J, et al. The UCSC genome browser database: 2014 update. Nucleic Acids Res. 2013 doi: 10.1093/nar/gkt1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mouse EC, Stamatoyannopoulos JA, Snyder M, et al. An encyclopedia of mouse DNA elements (mouse ENCODE) Genome Biol. 2012;13:418. doi: 10.1186/gb-2012-13-8-418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Gifford CA, Ziller MJ, Gu H, et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell. 2013;153:1149–63. doi: 10.1016/j.cell.2013.04.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xie W, Schultz MD, Lister R, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 2013;153:1134–48. doi: 10.1016/j.cell.2013.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Koh FM, Sachs M, Guzman-Ayala M, Ramalho-Santos M. Parallel gateways to pluripotency: Open chromatin in stem cells and development. Curr Opin Genet Dev. 2010;20:492–9. doi: 10.1016/j.gde.2010.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gaspar-Maia A, Alajem A, Meshorer E, Ramalho-Santos M. Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol. 2011;12:36–47. doi: 10.1038/nrm3036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mattout A, Meshorer E. Chromatin plasticity and genome organization in pluripotent embryonic stem cells. Curr Opin Cell Biol. 2010;22:334–41. doi: 10.1016/j.ceb.2010.02.001. [DOI] [PubMed] [Google Scholar]
  • 12.Meshorer E, Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol. 2006;7:540–6. doi: 10.1038/nrm1938. [DOI] [PubMed] [Google Scholar]
  • 13.Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat Rev Genet. 2007;8:263–71. doi: 10.1038/nrg2046. [DOI] [PubMed] [Google Scholar]
  • 14.Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol. 2010;28:1079–88. doi: 10.1038/nbt.1684. [DOI] [PubMed] [Google Scholar]
  • 15.Orkin SH, Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell. 2011;145:835–50. doi: 10.1016/j.cell.2011.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lessard JA, Crabtree GR. Chromatin regulatory mechanisms in pluripotency. Annu Rev Cell Dev Biol. 2010;26:503–32. doi: 10.1146/annurev-cellbio-051809-102012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fisher CL, Fisher AG. Chromatin states in pluripotent, differentiated, and reprogrammed cells. Curr Opin Genet Dev. 2011;21:140–6. doi: 10.1016/j.gde.2011.01.015. [DOI] [PubMed] [Google Scholar]
  • 18.Rivera CM, Ren B. Mapping human epigenomes. Cell. 2013;155:39–55. doi: 10.1016/j.cell.2013.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–6. doi: 10.1038/292154a0. [DOI] [PubMed] [Google Scholar]
  • 20.Dessypris E, Sawyer S. Erythropoiesis. In: Greer J, Foerster J, Rodgers G, Paraskevas F, Glader B, Arber D, Means RJ, editors. Wintrobe's Clinical Hematology. 12th ed Wolters Kluwer/Lippincott Williams & Wilkins; Philadelphia, PA: 2009. pp. 106–25. [Google Scholar]
  • 21.Skubitz K. Neutrophilic leukocytes. In: Greer J, Foerster J, Rodgers G, Paraskevas F, Glader B, Arber D, Means RJ, editors. Wintrobe's Clinical Hematology. 12th ed Wolters Kluwer/Lippincott Williams & Wilkins; Philadelphia, PA: 2009. pp. 170–213. [Google Scholar]
  • 22.Francastel C, Schubeler D, Martin DI, Groudine M. Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol. 2000;1:137–43. doi: 10.1038/35040083. [DOI] [PubMed] [Google Scholar]
  • 23.Efroni S, Duttagupta R, Cheng J, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2:437–47. doi: 10.1016/j.stem.2008.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell. 2006;10:105–16. doi: 10.1016/j.devcel.2005.10.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Eckfeldt CE, Mendenhall EM, Verfaillie CM. The molecular repertoire of the `almighty' stem cell. Nat Rev Mol Cell Biol. 2005;6:726–37. doi: 10.1038/nrm1713. [DOI] [PubMed] [Google Scholar]
  • 26.Gu B, Zhang J, Wu Y, et al. Proteomic analyses reveal common promiscuous patterns of cell surface proteins on human embryonic stem cells and sperms. PLoS One. 2011;6:e19386. doi: 10.1371/journal.pone.0019386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Akashi K, He X, Chen J, et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood. 2003;101:383–90. doi: 10.1182/blood-2002-06-1780. [DOI] [PubMed] [Google Scholar]
  • 28.Krause DS. Regulation of hematopoietic stem cell fate. Oncogene. 2002;21:3262–9. doi: 10.1038/sj.onc.1205316. [DOI] [PubMed] [Google Scholar]
  • 29.Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell. 2007;130:77–88. doi: 10.1016/j.cell.2007.05.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Min IM, Waterfall JJ, Core LJ, Munroe RJ, Schimenti J, Lis JT. Regulating rna polymerase pausing and transcription elongation in embryonic stem cells. Genes Dev. 2011;25:742–54. doi: 10.1101/gad.2005511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273–304. doi: 10.1146/annurev.biochem.77.062706.153223. [DOI] [PubMed] [Google Scholar]
  • 32.Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463:474–84. doi: 10.1038/nature08911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gaspar-Maia A, Alajem A, Polesso F, et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature. 2009;460:863–8. doi: 10.1038/nature08212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A. 2009;106:5187–91. doi: 10.1073/pnas.0812888106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ho L, Ronan JL, Wu J, et al. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci U S A. 2009;106:5181–6. doi: 10.1073/pnas.0812889106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Schaniel C, Ang YS, Ratnakumar K, et al. Smarcc1/BAF155 couples self-renewal gene repression with changes in chromatin structure in mouse embryonic stem cells. Stem Cells. 2009;27:2979–91. doi: 10.1002/stem.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lee JH, Hart SR, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis. 2004;38:32–8. doi: 10.1002/gene.10250. [DOI] [PubMed] [Google Scholar]
  • 38.Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet. 2009;41:246–50. doi: 10.1038/ng.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Di Croce L, Helin K. Transcriptional regulation by polycomb group proteins. Nat Struct Mol Biol. 2013;20:1147–55. doi: 10.1038/nsmb.2669. [DOI] [PubMed] [Google Scholar]
  • 40.Simon JA, Kingston RE. Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell. 2013;49:808–24. doi: 10.1016/j.molcel.2013.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Surface LE, Thornton SR, Boyer LA. Polycomb group proteins set the stage for early lineage commitment. Cell Stem Cell. 2010;7:288–98. doi: 10.1016/j.stem.2010.08.004. [DOI] [PubMed] [Google Scholar]
  • 42.Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life. Nature. 2011;469:343–9. doi: 10.1038/nature09784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Boyer LA, Plath K, Zeitlinger J, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349–53. doi: 10.1038/nature04733. [DOI] [PubMed] [Google Scholar]
  • 44.Lee TI, Jenner RG, Boyer LA, et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell. 2006;125:301–13. doi: 10.1016/j.cell.2006.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chamberlain SJ, Yee D, Magnuson T. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells. 2008;26:1496–505. doi: 10.1634/stemcells.2008-0102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Pasini D, Bracken AP, Hansen JB, Capillo M, Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol. 2007;27:3769–79. doi: 10.1128/MCB.01432-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Shen X, Liu Y, Hsu YJ, et al. Ezh1 mediates methylation on histone H3 lysine 27 and complements Ezh2 in maintaining stem cell identity and executing pluripotency. Mol Cell. 2008;32:491–502. doi: 10.1016/j.molcel.2008.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125:315–26. doi: 10.1016/j.cell.2006.02.041. [DOI] [PubMed] [Google Scholar]
  • 49.Voigt P, Tee WW, Reinberg D. A double take on bivalent promoters. Genes Dev. 2013;27:1318–38. doi: 10.1101/gad.219626.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhao XD, Han X, Chew JL, et al. Whole-genome mapping of histone H3 lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell. 2007;1:286–98. doi: 10.1016/j.stem.2007.08.004. [DOI] [PubMed] [Google Scholar]
  • 51.Pan G, Tian S, Nie J, et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell. 2007;1:299–312. doi: 10.1016/j.stem.2007.08.003. [DOI] [PubMed] [Google Scholar]
  • 52.Sharov AA, Ko MSH. Human ES cell profiling broadens the reach of bivalent domains. Cell Stem Cell. 2007;1:237–38. doi: 10.1016/j.stem.2007.08.015. [DOI] [PubMed] [Google Scholar]
  • 53.Smith ZD, Meissner A. DNA methylation: Roles in mammalian development. Nat Rev Genet. 2013;14:204–20. doi: 10.1038/nrg3354. [DOI] [PubMed] [Google Scholar]
  • 54.Bergman Y, Cedar H. DNA methylation dynamics in health and disease. Nat Struct Mol Biol. 2013;20:274–81. doi: 10.1038/nsmb.2518. [DOI] [PubMed] [Google Scholar]
  • 55.Meissner A, Mikkelsen TS, Gu H, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454:766–70. doi: 10.1038/nature07107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315–22. doi: 10.1038/nature08514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Laurent L, Wong E, Li G, et al. Dynamic changes in the human methylome during differentiation. Genome Res. 2010;20:320–31. doi: 10.1101/gr.101907.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992;69:915–26. doi: 10.1016/0092-8674(92)90611-f. [DOI] [PubMed] [Google Scholar]
  • 59.Okano M, Bell DW, Haber DA, Li W. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–57. doi: 10.1016/s0092-8674(00)81656-6. [DOI] [PubMed] [Google Scholar]
  • 60.Jackson M, Krassowska A, Gilbert N, et al. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol. 2004;24:8862–71. doi: 10.1128/MCB.24.20.8862-8871.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Pastor WA, Aravind L, Rao A. Tetonic shift: Biological roles of Tet proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol. 2013;14:341–56. doi: 10.1038/nrm3589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development. 2012;139:1895–902. doi: 10.1242/dev.070771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Koh KP, Rao A. DNA methylation and methylcytosine oxidation in cell fate decisions. Curr Opin Cell Biol. 2013;25:152–61. doi: 10.1016/j.ceb.2013.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Koh KP, Yabuuchi A, Rao S, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell. 2011;8:200–13. doi: 10.1016/j.stem.2011.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by Mll partner Tet1. Science. 2009;324:930–5. doi: 10.1126/science.1170116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Dawlaty MM, Breiling A, Le T, et al. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev Cell. 2013;24:310–23. doi: 10.1016/j.devcel.2012.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Wu H, Zhang Y. Tet1 and 5-hydroxymethylation: A genome-wide view in mouse embryonic stem cells. Cell Cycle. 2011;10:2428–36. doi: 10.4161/cc.10.15.16930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Dawlaty MM, Ganz K, Powell BE, et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell. 2011;9:166–75. doi: 10.1016/j.stem.2011.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Greve TS, Judson RL, Blelloch R. MicroRNA control of mouse and human pluripotent stem cell behavior. Annu Rev Cell Dev Biol. 2013;29:213–39. doi: 10.1146/annurev-cellbio-101512-122343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Sinkkonen L, Hugenschmidt T, Berninger P, et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008;15:259–67. doi: 10.1038/nsmb.1391. [DOI] [PubMed] [Google Scholar]
  • 71.Guo X, Liu Q, Wang G, et al. MicroRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming. Cell Res. 2013;23:142–56. doi: 10.1038/cr.2012.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.O'Loghlen A, Munoz-Cabello AM, Gaspar-Maia A, et al. MicroRNA regulation of Cbx7 mediates a switch of polycomb orthologs during ESC differentiation. Cell Stem Cell. 2012;10:33–46. doi: 10.1016/j.stem.2011.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Morey L, Pascual G, Cozzuto L, et al. Nonoverlapping functions of the polycomb group Cbx family of proteins in embryonic stem cells. Cell Stem Cell. 2012;10:47–62. doi: 10.1016/j.stem.2011.12.006. [DOI] [PubMed] [Google Scholar]
  • 74.Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–66. doi: 10.1146/annurev-biochem-051410-092902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Batista PJ, Chang HY. Long noncoding RNAs: Cellular address codes in development and disease. Cell. 2013;152:1298–307. doi: 10.1016/j.cell.2013.02.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Guttman M, Donaghey J, Carey BW, et al. LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477:295–300. doi: 10.1038/nature10398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Ng SY, Johnson R, Stanton LW. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012;31:522–33. doi: 10.1038/emboj.2011.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Nissim-Rafinia M, Meshorer E. Photobleaching assays (FRAP & FLIP) to measure chromatin protein dynamics in living embryonic stem cells. J Vis Exp. 2011 doi: 10.3791/2696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Melcer S, Hezroni H, Rand E, et al. Histone modifications and lamin a regulate chromatin protein dynamics in early embryonic stem cell differentiation. Nat Commun. 2012;3:910. doi: 10.1038/ncomms1915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Hinde E, Cardarelli F, Chen A, Khine M, Gratton E. Tracking the mechanical dynamics of human embryonic stem cell chromatin. Epigenetics Chromatin. 2012;5:20. doi: 10.1186/1756-8935-5-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Thurman RE, Rynes E, Humbert R, et al. The accessible chromatin landscape of the human genome. Nature. 2012;489:75–82. doi: 10.1038/nature11232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Song L, Zhang Z, Grasfeder LL, et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011;21:1757–67. doi: 10.1101/gr.121541.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Struhl K, Segal E. Determinants of nucleosome positioning. Nat Struct Mol Biol. 2013;20:267–73. doi: 10.1038/nsmb.2506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Teif VB, Vainshtein Y, Caudron-Herger M, et al. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol. 2012;19:1185–92. doi: 10.1038/nsmb.2419. [DOI] [PubMed] [Google Scholar]
  • 85.de Wit E, de Laat W. A decade of 3C technologies: Insights into nuclear organization. Genes Dev. 2012;26:11–24. doi: 10.1101/gad.179804.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Kagey MH, Newman JJ, Bilodeau S, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature. 2010;467:430–5. doi: 10.1038/nature09380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Zhang H, Jiao W, Sun L, et al. Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell. 2013;13:30–5. doi: 10.1016/j.stem.2013.05.012. [DOI] [PubMed] [Google Scholar]
  • 88.Wei Z, Gao F, Kim S, et al. Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency. Cell Stem Cell. 2013;13:36–47. doi: 10.1016/j.stem.2013.05.010. [DOI] [PubMed] [Google Scholar]
  • 89.de Wit E, Bouwman BA, Zhu Y, et al. The pluripotent genome in three dimensions is shaped around pluripotency factors. Nature. 2013;501:227–31. doi: 10.1038/nature12420. [DOI] [PubMed] [Google Scholar]
  • 90.Apostolou E, Ferrari F, Walsh RM, et al. Genome-wide chromatin interactions of the nanog locus in pluripotency, differentiation, and reprogramming. Cell Stem Cell. 2013;12:699–712. doi: 10.1016/j.stem.2013.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Dixon JR, Selvaraj S, Yue F, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485:376–80. doi: 10.1038/nature11082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Phillips-Cremins JE, Sauria ME, Sanyal A, et al. Architectural protein subclasses shape 3d organization of genomes during lineage commitment. Cell. 2013;153:1281–95. doi: 10.1016/j.cell.2013.04.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Handoko L, Xu H, Li G, et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat Genet. 2011;43:630–8. doi: 10.1038/ng.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Merkenschlager M, Odom DT. CTCF and cohesin: Linking gene regulatory elements with their targets. Cell. 2013;152:1285–97. doi: 10.1016/j.cell.2013.02.029. [DOI] [PubMed] [Google Scholar]
  • 95.Peric-Hupkes D, Meuleman W, Pagie L, et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell. 2010;38:603–13. doi: 10.1016/j.molcel.2010.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Young RA. Control of the embryonic stem cell state. Cell. 2011;144:940–54. doi: 10.1016/j.cell.2011.01.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008;132:567–82. doi: 10.1016/j.cell.2008.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Loh KM, Lim B. A precarious balance: Pluripotency factors as lineage specifiers. Cell Stem Cell. 2011;8:363–9. doi: 10.1016/j.stem.2011.03.013. [DOI] [PubMed] [Google Scholar]
  • 99.Chou BK, Cheng L. And then there were none: No need for pluripotency factors to induce reprogramming. Cell Stem Cell. 2013;13:261–2. doi: 10.1016/j.stem.2013.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Thomson M, Liu SJ, Zou LN, Smith Z, Meissner A, Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell. 2011;145:875–89. doi: 10.1016/j.cell.2011.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Wang Z, Oron E, Nelson B, Razis S, Ivanova N. Distinct lineage specification roles for Nanog, Oct4, and Sox2 in human embryonic stem cells. Cell Stem Cell. 2012;10:440–54. doi: 10.1016/j.stem.2012.02.016. [DOI] [PubMed] [Google Scholar]
  • 102.Shu J, Wu C, Wu Y, et al. Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell. 2013;153:963–75. doi: 10.1016/j.cell.2013.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Montserrat N, Nivet E, Sancho-Martinez I, et al. Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell. 2013;13:341–50. doi: 10.1016/j.stem.2013.06.019. [DOI] [PubMed] [Google Scholar]

RESOURCES